Notices of Compliance, 2013
1,114 notices issued in 2013, newest first.
| Date | Products | Company | Submission |
|---|---|---|---|
| December 30, 2013 | 12HR BODY LIQUID GELS | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | New Drug Submission (NDS) · Other |
| December 30, 2013 | JAMP-CLOPIDOGREL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| December 27, 2013 | MYLAN-DONEPEZIL | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| December 27, 2013 | MAR-DONEPEZIL | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 27, 2013 | DONEPEZIL | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| December 27, 2013 | RIVA-DONEPEZIL | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 27, 2013 | BIO-DONEPEZIL | Biomed 2002 Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| December 27, 2013 | FENTANYL CITRATE INJECTION USP | Alveda Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 27, 2013 | JAMP-DONEPEZIL TABLETS | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| December 27, 2013 | JAMP-DONEPEZIL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| December 27, 2013 | MYLAN-DONEPEZIL | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 27, 2013 | DONEPEZIL HYDROCHLORIDE TABLETS USP | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| December 27, 2013 | IPG-DONEPEZIL | International Pharmaceutical Generics Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| December 24, 2013 | MINT-DONEPEZIL | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| December 24, 2013 | PMS-DONEPEZIL | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 24, 2013 | SANDOZ DONEPEZIL | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 24, 2013 | SANDOZ DONEPEZIL ODT | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 24, 2013 | APO-DONEPEZIL | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 24, 2013 | RAN-DONEPEZIL | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 24, 2013 | TEVA-DONEPEZIL | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| December 24, 2013 | TARO-AMCINONIDE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 24, 2013 | DONEPEZIL HYDROCHLORIDE | Jubilant Life Sciences Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 24, 2013 | APO-DONEPEZIL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 24, 2013 | AURO-DONEPEZIL | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 24, 2013 | CO DONEPEZIL ODT | Cobalt Pharmaceuticals Incorporated | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 24, 2013 | DONEPEZIL HYDROCHLORIDE | Jubilant Life Sciences Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| December 24, 2013 | CO DONEPEZIL | Cobalt Pharmaceuticals Incorporated | Abbreviated New Drug Submission (ANDS) · Other |
| December 24, 2013 | DONEPEZIL HYDROCHLORIDE TABLETS | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| December 24, 2013 | CORIFACT 250; CORIFACT 1250 | Csl Behring Canada Inc | New Drug Submission (NDS) · Other |
| December 24, 2013 | CONVENIA | Zoetis Canada Inc | New Drug Submission (NDS) · Admin |
| December 24, 2013 | TORBUGESIC | Zoetis Canada Inc | New Drug Submission (NDS) · Admin |
| December 23, 2013 | ANORO ELLIPTA | Glaxosmithkline Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| December 23, 2013 | INVEGA SUSTENNA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 23, 2013 | ULTIBRO BREEZHALER | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Other |
| December 23, 2013 | ATORVASTATIN CALCIUM TABLETS | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| December 23, 2013 | PHARMASIN 100 | Huvepharma Eood | Abbreviated New Drug Submission (ANDS) · Other |
| December 23, 2013 | GAMMAGARD LIQUID | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| December 20, 2013 | CYCLOCORT | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 20, 2013 | PROMETRIUM | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 20, 2013 | INCIVEK | Vertex Pharmaceuticals (Canada) Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| December 20, 2013 | AURO-CARVEDILOL | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 19, 2013 | WINDEX MULTI-SURFACE DISINFECTANT II | S.C. Johnson and Son Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 19, 2013 | ARTISS - KIT (SYNTHETIC APROTININ); ARTISS - KIT (BOVINE APROTININ); ARTISS - FROZEN (SYNTHETIC APROTININ); ARTISS - FROZEN (BOVINE APROTININ) | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| December 19, 2013 | PMS-IRBESARTAN-HCTZ | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 19, 2013 | SANDOZ ENTECAVIR | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 19, 2013 | CO RALOXIFENE | Cobalt Pharmaceuticals Incorporated | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 19, 2013 | LEVEMIR (FLEXPEN); LEVEMIR (INNOLET); LEVEMIR (PENFILL); LEVEMIR (FLEXTOUCH) | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 19, 2013 | NOVO-PROFEN | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| December 19, 2013 | NOVO-PROFEN | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| December 19, 2013 | GAMMAGARD LIQUID | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| December 18, 2013 | TORRENT-PIOGLITAZONE | Torrent Pharmaceuticals Limited | Abbreviated New Drug Submission (ANDS) · Other |
| December 18, 2013 | HUMIRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| December 18, 2013 | ENBREL | Immunex Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| December 17, 2013 | PMS-GABAPENTIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 17, 2013 | AURO-EFAVIRENZ | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 17, 2013 | APO-SILDENAFIL R | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 16, 2013 | TEVA-BISOPROLOL | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| December 13, 2013 | SOVALDI | Gilead Sciences Canada Inc | New Drug Submission (NDS) · Priority-NAS |
| December 12, 2013 | LEMTRADA | Genzyme Canada A Division Of Sanofi-Aventis Canada Inc | New Drug Submission (NDS) · Other |
| December 12, 2013 | LOLO | Warner Chilcott Canada Co | New Drug Submission (NDS) · Other |
| December 12, 2013 | BAYCOX | Bayer Inc Bayer Healthcare Animal Health | Supplement to a New Drug Submission (SNDS) · Other |
| December 12, 2013 | PLANATE | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| December 12, 2013 | ZUPREVO | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| December 12, 2013 | ILARIS | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 12, 2013 | GRASTEK | Merck Canada Inc | New Drug Submission (NDS) · Other |
| December 12, 2013 | XGEVA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 12, 2013 | SEMINTRA 4 MG/ML ORAL SOLUTION | Boehringer Ingelheim (Canada) Ltd. | New Drug Submission (NDS) · Other |
| December 12, 2013 | XOFIGO (RADIUM-223 DICHLORIDE) | Bayer Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| December 12, 2013 | SPECTRAMAST LC | Zoetis Canada Inc | New Drug Submission (NDS) · Admin |
| December 12, 2013 | SPECTRAMAST DC | Zoetis Canada Inc | New Drug Submission (NDS) · Admin |
| December 11, 2013 | PMS-RISEDRONATE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 11, 2013 | PMS-IRBESARTAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 11, 2013 | JANUMET XR | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 10, 2013 | ULORIC | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| December 10, 2013 | REVOLUTION | Zoetis Canada Inc | New Drug Submission (NDS) · Admin |
| December 10, 2013 | REVOLUTION | Zoetis Canada Inc | New Drug Submission (NDS) · Admin |
| December 10, 2013 | REVOLUTION | Zoetis Canada Inc | New Drug Submission (NDS) · Admin |
| December 10, 2013 | REVOLUTION | Zoetis Canada Inc | New Drug Submission (NDS) · Admin |
| December 10, 2013 | REVOLUTION | Zoetis Canada Inc | New Drug Submission (NDS) · Admin |
| December 10, 2013 | REVOLUTION | Zoetis Canada Inc | New Drug Submission (NDS) · Admin |
| December 10, 2013 | REVOLUTION | Zoetis Canada Inc | New Drug Submission (NDS) · Admin |
| December 10, 2013 | REVOLUTION | Zoetis Canada Inc | New Drug Submission (NDS) · Admin |
| December 10, 2013 | NOVO-CYPROTERONE/ETHINYL ESTRADIOL | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| December 10, 2013 | MINT-PANTOPRAZOLE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| December 10, 2013 | NAT-ALPRAZOLAM | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| December 10, 2013 | SANDOZ CANDESARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 9, 2013 | JENTADUETO | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| December 9, 2013 | CLOPROSTENOL VEYX | Modern Veterinary Therapeutics Llc | Abbreviated New Drug Submission (ANDS) · Other |
| December 9, 2013 | ONSIOR | Novartis Animal Health Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 9, 2013 | ACCEL-PIOGLITAZONE | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| December 9, 2013 | PIOGLITAZONE | Accel Pharma Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 9, 2013 | MAR-PANTOPRAZOLE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 9, 2013 | MYLAN-CIPROFLOXACIN XL | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| December 9, 2013 | ACTIVASE RT-PA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2013 | ABREVA | Glaxosmithkline Consumer Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2013 | BEXSERO | Novartis Vaccines And Diagnostics Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| December 5, 2013 | QUETIAPINE XR | Sivem Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| December 5, 2013 | CO OLOPATADINE 0.1% | Cobalt Pharmaceuticals Incorporated | Abbreviated New Drug Submission (ANDS) · Other |
| December 5, 2013 | ACTEMRA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 4, 2013 | ALDARA P | Valeant Canada Lp Valeant Canada S.E.C. | Supplement to a New Drug Submission (SNDS) · Other |
| December 4, 2013 | RIVASTIGMINE | Pro Doc Limitee | New Drug Submission (NDS) · Admin |
| December 4, 2013 | ZOSTAVAX; ZOSTAVAX II | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 4, 2013 | VARIVAX III | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 4, 2013 | PROQUAD | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 4, 2013 | ESTROPLAN | Parnell Technologies Pty Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 4, 2013 | CEFTIOCYL | Vetoquinol N A Inc | Abbreviated New Drug Submission (ANDS) · Other |
| December 3, 2013 | TESTIM 1% | Auxilium Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 3, 2013 | ADVANTAGE MULTI 9 | Bayer Inc Bayer Healthcare Animal Health | Supplement to a New Drug Submission (SNDS) · Other |
| December 3, 2013 | CERENIA | Zoetis Canada Inc | New Drug Submission (NDS) · Admin |
| December 3, 2013 | CERENIA | Zoetis Canada Inc | New Drug Submission (NDS) · Admin |
| December 3, 2013 | CERENIA | Zoetis Canada Inc | New Drug Submission (NDS) · Admin |
| December 3, 2013 | CERENIA | Zoetis Canada Inc | New Drug Submission (NDS) · Admin |
| December 3, 2013 | METHOTREXATE INJECTION USP | Onco Therapies Limited | Abbreviated New Drug Submission (ANDS) · Other |
| December 3, 2013 | RECLIPSEN 28 | Actavis Pharma Company | Abbreviated New Drug Submission (ANDS) · Other |
| December 2, 2013 | GALANTAMINE ER | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| December 2, 2013 | JEVTANA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 2, 2013 | CONSTELLA | Forest Laboratories Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 29, 2013 | TYGACIL | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 29, 2013 | SPRYCEL | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| November 29, 2013 | JAMP OLANZAPINE (ODT) | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| November 29, 2013 | INNOHEP | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2013 | RAN-DOMPERIDONE | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 28, 2013 | MOGADON | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| November 28, 2013 | SIMPONI I.V. | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 27, 2013 | RIVA-MEMANTINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 27, 2013 | RIZATRIPTAN RDT | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| November 27, 2013 | ALLOPURINOL-100; ALLOPURINOL-200; ALLOPURINOL-300 | Pro Doc Limitee | New Drug Submission (NDS) · Admin |
| November 27, 2013 | APO-QUINAPRIL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 27, 2013 | APO-QUINAPRIL/HCTZ | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 27, 2013 | NESINA | Takeda Canada Incorporated | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 27, 2013 | KAZANO | Takeda Canada Incorporated | New Drug Submission (NDS) · Other |
| November 27, 2013 | MYLAN-CYCLOBENZAPRINE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 27, 2013 | JURAMATE | Jurox Pty Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 27, 2013 | DRAXXIN | Zoetis Canada Inc | New Drug Submission (NDS) · Admin |
| November 26, 2013 | ALLERGY CONTROL DESLORATADINE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 26, 2013 | RAMIPRIL-HCTZ | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| November 26, 2013 | QUINAPRIL | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| November 26, 2013 | RIVA-GLYBURIDE | Pharmel Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| November 26, 2013 | REPAGLINIDE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| November 26, 2013 | LEFLUNOMIDE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| November 26, 2013 | LEVOFLOXACIN | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| November 26, 2013 | RALOXIFENE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| November 26, 2013 | AZITHROMYCIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 26, 2013 | DOMPERIDONE | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 26, 2013 | XGEVA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 26, 2013 | SOMAVERT | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 25, 2013 | ALERTEC | Teva Pharma B.V. | Supplement to a New Drug Submission (SNDS) · Other |
| November 22, 2013 | WINDEX MULTI-SURFACE ANTIBACTERIAL DISINFECTANT 2 | S.C. Johnson and Son Limited | New Drug Submission (NDS) · Other |
| November 22, 2013 | PREGABALIN | Alembic Pharmaceuticals Limited | Abbreviated New Drug Submission (ANDS) · Other |
| November 22, 2013 | SCRUBBING BUBBLES BATHROOM CLEANER DISINFECTANT | S.C. Johnson and Son Limited | New Drug Submission (NDS) · Other |
| November 22, 2013 | VOLTAREN EMULGEL - JOINT PAIN | Novartis Consumer Health Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 22, 2013 | MINT-ANASTROZOLE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 22, 2013 | AURO-CLOPIDOGREL | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 22, 2013 | OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 22, 2013 | SANDOZ TACROLIMUS | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 21, 2013 | NATAZIA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 21, 2013 | QISMETTE 21; QISMETTE 28 | Lupin Limited | Abbreviated New Drug Submission (ANDS) · Other |
| November 21, 2013 | NOVO-BICALUTAMIDE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| November 21, 2013 | FENTORA | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| November 21, 2013 | EPIRUBICIN FOR INJECTION | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| November 21, 2013 | DAUNORUBICIN HYDROCHLORIDE FOR INJECTION | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| November 21, 2013 | TEVA-FROVATRIPTAN | Endo Pharmaceuticals Inc | New Drug Submission (NDS) · Admin |
| November 21, 2013 | CEFOXITIN FOR INJECTION | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| November 21, 2013 | PMS-NIFEDIPINE ER | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 21, 2013 | PMS-CIPROFLOXACIN XL | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 21, 2013 | APO-BIMATOPROST | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 21, 2013 | HUMIRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| November 21, 2013 | IMVAMUNE (MVA-BN SMALL POX VACCINE) | Bavarian Nordic As | New Drug Submission (NDS) · Other |
| November 20, 2013 | AZASITE | Inspire Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 20, 2013 | THYMOGLOBULIN | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 19, 2013 | PREZISTA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 19, 2013 | PB-SILDENAFIL | Pb Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| November 19, 2013 | PMS-FUROSEMIDE | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| November 19, 2013 | PMS-HYDROCHLOROTHIAZIDE | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| November 19, 2013 | CANINSULIN | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| November 18, 2013 | APO-CARBAMAZEPINE CR | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 18, 2013 | GALEXOS | Janssen Inc. | New Drug Submission (NDS) · Priority-NAS |
| November 15, 2013 | RAN-QUINAPRIL | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 15, 2013 | PMS-QUINAPRIL | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 15, 2013 | GARDASIL | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 15, 2013 | RAN-OXYCODONE CR | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 15, 2013 | RAN-OXYCODONE CR | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 15, 2013 | IRBESARTAN | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 14, 2013 | AUBAGIO | Genzyme Canada A Division Of Sanofi-Aventis Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 13, 2013 | AURO-SIMVASTATIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 13, 2013 | FLUDARABINE PHOSPHATE INJECTION | Omega Laboratories Limited | Abbreviated New Drug Submission (ANDS) · Other |
| November 13, 2013 | APO-AZITHROMYCIN Z | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 13, 2013 | IPG-CANDESARTAN | International Pharmaceutical Generics Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| November 13, 2013 | MENINGITEC | Nuron Biotech B.V. | New Drug Submission (NDS) · Admin |
| November 12, 2013 | ASPIRIN 81 MG; ASPIRIN 81 MG QUICK CHEWS; ASPIRIN REGULAR STRENGTH | Bayer Inc Consumer Care | Supplement to a New Drug Submission (SNDS) · Other |
| November 12, 2013 | METACAM 20 MG/ML SOLUTION FOR INJECTION | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| November 12, 2013 | ESTRUMATE | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| November 12, 2013 | ADVIL ARTHRITIS PAIN | Pfizer Consumer Healthcare, a division of Pfizer Canada ULC | New Drug Submission (NDS) · Labelling Only |
| November 8, 2013 | ALFUZOSIN | Pro Doc Limitee | New Drug Submission (NDS) · Admin |
| November 8, 2013 | EYLEA | Bayer Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 7, 2013 | NOZINAN | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 7, 2013 | LOSARTAN POTASSIUM | Jubilant Life Sciences Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 7, 2013 | ABBOTT-OLANZAPINE ODT | Abbott Laboratories Co. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 7, 2013 | CARBOPLATIN INJECTION | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| November 7, 2013 | ANGELIQ | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 7, 2013 | YAZ | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 7, 2013 | PREGABALIN | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 6, 2013 | ABBOTT-LEVETIRACETAM | Abbott Laboratories Co. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 6, 2013 | OPSUMIT | Actelion Pharmaceuticals Ltd | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 5, 2013 | DOM-LANSOPRAZOLE | Dominion Pharmacal | Abbreviated New Drug Submission (ANDS) · Admin |
| November 5, 2013 | PMS-DIAZEPAM | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| November 5, 2013 | IRBESARTAN | Jubilant Life Sciences Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 5, 2013 | MOMETASONE | Frosst A Division Of Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Admin |
| November 5, 2013 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Jubilant Life Sciences Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 4, 2013 | TARO-LATANOPROST | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 4, 2013 | DUREZOL | Alcon Canada Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 4, 2013 | ABBOTT-CITALOPRAM | Abbott Laboratories Co. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 4, 2013 | ABBOTT-TOPIRAMATE | Abbott Laboratories Co. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 4, 2013 | DOM-VALSARTAN | Dominion Pharmacal | Abbreviated New Drug Submission (ANDS) · Admin |
| November 1, 2013 | GIOTRIF | Boehringer Ingelheim (Canada) Ltd. | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 1, 2013 | SANDOZ TRAVOPROST / TIMOLOL | Sandoz Canada Inc. | New Drug Submission (NDS) · Admin |
| November 1, 2013 | CLINIMIX (BLEND B); CLINIMIX (BLEND C) | Baxter Corporation | New Drug Submission (NDS) · Admin |
| November 1, 2013 | FASLODEX | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 31, 2013 | TIVICAY | Viiv Healthcare Ulc | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 31, 2013 | CARBAMAZEPINE CR | Pro Doc Limitee | New Drug Submission (NDS) · Admin |
| October 31, 2013 | CLINIMIX E (BLEND B); CLINIMIX E (BLEND C) | Baxter Corporation | New Drug Submission (NDS) · Admin |
| October 31, 2013 | IMIQUIMOD 5% | Valeant Canada Lp Valeant Canada S.E.C. | New Drug Submission (NDS) · Admin |
| October 31, 2013 | TAMSULOSIN CR | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| October 31, 2013 | NTP-TELMISARTAN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| October 31, 2013 | DIARRHEA RELIEF | Teva Canada Limited | New Drug Submission (NDS) · Labelling Only |
| October 31, 2013 | NTP-LISINOPRIL/HCTZ (TYPE Z) | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| October 31, 2013 | NTP-LISINOPRIL/HCTZ (TYPE P) | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| October 31, 2013 | NUCYNTA EXTENDED RELEASE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 30, 2013 | MINT-ONDANSETRON | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| October 30, 2013 | PANTOPRAZOLE | International Pharmaceutical Generics Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| October 29, 2013 | TORRENT-RABEPRAZOLE SODIUM | Torrent Pharmaceuticals Limited | Abbreviated New Drug Submission (ANDS) · Other |
| October 29, 2013 | AURO-PANTOPRAZOLE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 29, 2013 | IPG-PANTOPRAZOLE | International Pharmaceutical Generics Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| October 28, 2013 | NTP-MORPHINE SR | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| October 25, 2013 | ZOLINZA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2013 | MEROPENEM FOR INJECTION, USP | Pharmaceutical Partners Of Canada Inc | Abbreviated New Drug Submission (ANDS) · Other |
| October 25, 2013 | MAR-ROSUVASTATIN | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 25, 2013 | MERCAPTOPURINE TABLETS USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 24, 2013 | ACID REDUCER | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 23, 2013 | EXELON PATCH | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 23, 2013 | AURO-LAMIVUDINE/ZIDOVUDINE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 22, 2013 | INCIVEK | Vertex Pharmaceuticals (Canada) Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| October 22, 2013 | SANDOZ TRAVOPROST | Sandoz Canada Inc. | New Drug Submission (NDS) · Admin |
| October 22, 2013 | ABBOTT-QUETIAPINE | Abbott Laboratories Co. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 22, 2013 | ABBOTT-CLOPIDOGREL | Abbott Laboratories Co. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 22, 2013 | ABBOTT-PANTOPRAZOLE | Abbott Laboratories Co. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 22, 2013 | NOVO-NABUMETONE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| October 22, 2013 | TACTUPUMP | Galderma Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 22, 2013 | REACTINE COMPLETE | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 22, 2013 | IPG-ROSUVASTATIN | International Pharmaceutical Generics Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| October 22, 2013 | PRISTIQ | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 22, 2013 | DOXORUBICIN HYDROCHLORIDE INJECTION, USP | Onco Therapies Limited | Abbreviated New Drug Submission (ANDS) · Other |
| October 21, 2013 | FOSAMAX | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 21, 2013 | SANDOZ MEMANTINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 21, 2013 | MINT-PRAVASTATIN | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| October 18, 2013 | NTP-NAPROXEN; NTP-NAPROXEN EC | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| October 18, 2013 | NTP-MONTELUKAST | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| October 18, 2013 | NTP-MIRTAZAPINE OD | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| October 18, 2013 | NTP-MIRTAZAPINE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| October 18, 2013 | PHARIXIA | Pendopharm Division Of De Pharmascience Inc | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| October 18, 2013 | AURO-VALSARTAN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 18, 2013 | PREMARIN | Pfizer Canada Ulc | New Drug Submission (NDS) · Other |
| October 17, 2013 | ACTEMRA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 16, 2013 | METONIA | Pendopharm Division Of De Pharmascience Inc | New Drug Submission (NDS) · Labelling Only |
| October 16, 2013 | ABRAXANE | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 16, 2013 | AURO-SILDENAFIL | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 16, 2013 | NTP-LORAZEPAM | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| October 16, 2013 | NTP-NAPROXEN SODIUM; NTP-NAPROXEN SODIUM DS | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| October 16, 2013 | NTP-METOPROLOL (FILM COATED); NTP-METOPROLOL | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| October 16, 2013 | NTP-LEFLUNOMIDE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| October 16, 2013 | RAN-OLANZAPINE ODT | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 16, 2013 | ISTODAX | Celgene Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 15, 2013 | ALLEGRA-D | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2013 | RISPERIDONE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 11, 2013 | CARVEDILOL | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 11, 2013 | NASACORT AQ | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2013 | TEVA-VALGANCICLOVIR | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| October 11, 2013 | PREVNAR 13 | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 10, 2013 | VOLIBRIS | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 10, 2013 | DOCETAXEL FOR INJECTION | Hospira Healthcare Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| October 10, 2013 | BOTOX | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 10, 2013 | LATUDA | Sunovion Pharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 10, 2013 | APO-LATANOPROST-TIMOP | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 10, 2013 | VPI-BACLOFEN INTRATHECAL | Valeo Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 10, 2013 | TARO-TERCONAZOLE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 10, 2013 | MEROPENEM FOR INJECTION | Hospira Healthcare Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| October 10, 2013 | TEVA-RISEDRONATE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 10, 2013 | PMS-METHYLPHENIDATE ER | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 10, 2013 | RHEUMOCAM (5 MG/ML INJ DOGS & CATS) | Chanelle Pharmaceuticals Manufacturing Limited | Abbreviated New Drug Submission (ANDS) · Other |
| October 9, 2013 | NTP-LEVOFLOXACIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| October 9, 2013 | GABAPENTIN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 9, 2013 | RAMIPRIL-HCTZ | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 9, 2013 | ZOPICLONE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 8, 2013 | NTP-PAROXETINE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| October 8, 2013 | NTP-INDOMETHACIN | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| October 8, 2013 | AURO-PAROXETINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 8, 2013 | DEFINITY | Lantheus Mi Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 7, 2013 | TRAVASOL E; TRAVASOL (BLEND B); TRAVASOL (BLEND C) | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Admin |
| October 7, 2013 | NTP-OLANZAPINE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| October 4, 2013 | STIVARGA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 4, 2013 | VESANOID | Cheplapharm Arzneimittel Gmbh Germany | New Drug Submission (NDS) · Admin |
| October 4, 2013 | NTP-SUMATRIPTAN DF | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| October 4, 2013 | MAR-PAROXETINE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 4, 2013 | FLUOROURACIL INJECTION | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| October 4, 2013 | AURO-LEVETIRACETAM | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2013 | SANDOZ ROSUVASTATIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2013 | NTP-TELMISARTAN HCTZ | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| October 4, 2013 | ISENTRESS | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 4, 2013 | DRYMIRA | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| October 3, 2013 | MYLAN-RISPERIDONE ODT | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| October 2, 2013 | JUBLIA | Valeant Canada Lp Valeant Canada S.E.C. | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 2, 2013 | STRIBILD | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 2, 2013 | AMOXICILLIN; AMOXICILLIN (SUGAR REDUCED) | Sanis Health Inc. | New Drug Submission (NDS) · Admin |
| October 1, 2013 | MED-EXEMESTANE | Generic Medical Partners Inc | Abbreviated New Drug Submission (ANDS) · Other |
| October 1, 2013 | PMS-DICLOFENAC-MISOPROSTOL | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 1, 2013 | VINCRISTINE SULFATE INJECTION USP | Hospira Healthcare Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 30, 2013 | PMS-CICLOPIROX | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 30, 2013 | AHI-TEMOZOLOMIDE CAPSULES | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 30, 2013 | MYLAN-CANDESARTAN HCTZ | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 27, 2013 | P-OCTREOTIDE ACETATE | Pendopharm Division Of De Pharmascience Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 27, 2013 | AURO-LAMOTRIGINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 26, 2013 | VIREAD | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 26, 2013 | PACLITAXEL FOR INJECTION | Biolyse Pharma Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| September 26, 2013 | NTP-NORFLOXACIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| September 26, 2013 | NTP-VENLAFAXINE XR | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| September 26, 2013 | NTP-ZOPICLONE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| September 24, 2013 | EPIRUBICIN HYDROCHLORIDE INJECTION | Onco Therapies Limited | Abbreviated New Drug Submission (ANDS) · Other |
| September 24, 2013 | APO-TEMOZOLOMIDE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 24, 2013 | HERCEPTIN | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 23, 2013 | GEMCITABINE INJECTION | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 23, 2013 | CISPLATIN INJECTION BP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 23, 2013 | SIGNIFOR | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 23, 2013 | RASILEZ | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 20, 2013 | LIORESAL | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 20, 2013 | LIORESAL IT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 20, 2013 | MINT-PIOGLITAZONE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 20, 2013 | CLARITIN KIDS | Schering-Plough Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 19, 2013 | TAXOTERE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 19, 2013 | ADEMPAS | Bayer Inc. | New Drug Submission (NDS) · Priority-NAS |
| September 19, 2013 | SIMPONI | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2013 | MYLAN-BUPROPION XL | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| September 17, 2013 | JEVTANA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 17, 2013 | IPG-PAROXETINE | International Pharmaceutical Generics Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| September 17, 2013 | NOVO-LOPERAMIDE | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| September 16, 2013 | MYLAN-REPAGLINIDE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 16, 2013 | MOGADON | AA Pharma Inc. | New Drug Submission (NDS) · Admin |
| September 16, 2013 | SANDOZ MOXIFLOXACIN | Sandoz Canada Inc. | New Drug Submission (NDS) · Admin |
| September 16, 2013 | AJ-IDARUBICIN | Agila Jamp Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 16, 2013 | NAGLAZYME | Biomarin Pharmaceutical Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 13, 2013 | NTP-IRBESARTAN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| September 13, 2013 | NTP-IRBESARTAN/HCTZ | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| September 13, 2013 | NTP-LANSOPRAZOLE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| September 12, 2013 | PREGABALIN-25; PREGABALIN-50; PREGABALIN-75; PREGABALIN-150; PREGABALIN-225; PREGABALIN-300 | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 11, 2013 | TRELSTAR | Paladin Labs Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2013 | DOCETAXEL INJECTION | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| September 11, 2013 | IRINOTECAN HYDROCHLORIDE INJECTION | Alveda Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 11, 2013 | PMS-SILDENAFIL R | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 11, 2013 | OMEPRAZOLE-20 | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 11, 2013 | RAMIPRIL-1.25; RAMIPRIL-2.5; RAMIPRIL-5; RAMIPRIL-10; RAMIPRIL-15 | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 11, 2013 | ROSUVASTATIN-5; ROSUVASTATIN-10; ROSUVASTATIN-20; ROSUVASTATIN-40 | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 11, 2013 | KADCYLA | Hoffmann-La Roche Limited | New Drug Submission (NDS) · Priority-NAS |
| September 11, 2013 | BERINERT | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 10, 2013 | APO-BIMATOPROST | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 10, 2013 | RAMIPRIL CAPSULES | Ranbaxy Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 9, 2013 | COMPLETE REVITALENS MULTI-PURPOSE DISINFECTING SOLUTION | Amo Canada Company | Supplement to a New Drug Submission (SNDS) · Admin |
| September 9, 2013 | NTP-FINASTERIDE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| September 9, 2013 | RISEDRONATE-35 | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 9, 2013 | NTP-GABAPENTIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| September 9, 2013 | NTP-INDAPAMIDE | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| September 6, 2013 | CEFTIOFUR SODIUM FOR INJECTION | Bio Agri Mix Lp | Abbreviated New Drug Submission (ANDS) · Other |
| September 6, 2013 | GEMCITABINE FOR INJECTION | Pharmaceutical Partners Of Canada Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 6, 2013 | CENTRISA (21 DAYS); CENTRISA (28 DAYS) | Patriot A Division Of Janssen Inc | New Drug Submission (NDS) · Labelling Only |
| September 6, 2013 | SARENSIS (21 DAY); SARENSIS (28 DAY) | Patriot A Division Of Janssen Inc | New Drug Submission (NDS) · Labelling Only |
| September 6, 2013 | CENTRISA LO (21 DAY); CENTRISA LO (28 DAY) | Patriot A Division Of Janssen Inc | New Drug Submission (NDS) · Labelling Only |
| September 6, 2013 | APO-LETROZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 6, 2013 | NTP-FENOFIBRATE-S | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| September 6, 2013 | NTP-FUROSEMIDE | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| September 5, 2013 | PROLIA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 5, 2013 | VEREGEN | Triton Pharma Inc. | New Drug Submission (NDS) · Other |
| September 5, 2013 | LEUKINE | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Admin |
| September 5, 2013 | FELIMAZOLE 1.25 MG | Dechra Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| September 5, 2013 | PRASCEND | Boehringer Ingelheim (Canada) Ltd. | New Drug Submission (NDS) · Other |
| September 4, 2013 | MINT-OLANZAPINE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 4, 2013 | PARNATE | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 3, 2013 | PHL-ROSIGLITAZONE | Pharmel Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 3, 2013 | DOM-ROSIGLITAZONE | Dominion Pharmacal | Abbreviated New Drug Submission (ANDS) · Admin |
| August 30, 2013 | GABAPENTIN TABLETS USP | Glenmark Generics Canada Inc | Abbreviated New Drug Submission (ANDS) · Other |
| August 30, 2013 | AURO-MIRTAZAPINE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 30, 2013 | MYLAN-DORZOLAMIDE/TIMOLOL | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| August 29, 2013 | VYVANSE | Shire Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 29, 2013 | TEVA-PACLITAXEL FOR INJECTION | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| August 29, 2013 | PACLITAXEL FOR INJECTION | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| August 29, 2013 | ATORVASTATIN-10; ATORVASTATIN-20; ATORVASTATIN-40; ATORVASTATIN-80 | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| August 28, 2013 | SILDENAFIL TABLETS | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| August 28, 2013 | ULTRATAG RBC | Mallinckrodt Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 27, 2013 | TYBOST | Gilead Sciences Canada Inc | New Drug Submission (NDS) · Other |
| August 27, 2013 | VITEKTA | Gilead Sciences Canada Inc | New Drug Submission (NDS) · Other |
| August 27, 2013 | MED-MEMANTINE | Generic Medical Partners Inc | Abbreviated New Drug Submission (ANDS) · Other |
| August 27, 2013 | IMODIUM COMPLETE CAPLETS; IMODIUM COMPLETE CHEWABLE TABLETS | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2013 | APO-AMLODIPINE-ATORVASTATIN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 23, 2013 | LEVEMIR | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2013 | VICTOZA | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 22, 2013 | ASMANEX TWISTHALER | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 22, 2013 | ILEVRO | Alcon Canada Inc. | New Drug Submission (NDS) · Other |
| August 22, 2013 | VOLTAREN EMULGEL | Novartis Consumer Health Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 21, 2013 | PRECEDEX | Hospira Healthcare Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| August 21, 2013 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 21, 2013 | HUMIRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| August 21, 2013 | MENVEO | Novartis Vaccines And Diagnostics Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 21, 2013 | CEREBYX | Erfa Canada 2012 Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 21, 2013 | RATIO-SALBUTAMOL | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| August 21, 2013 | IRINOTECAN | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| August 21, 2013 | AJ-ADENOSINE (PRE FILLED SYRINGE) | Agila Jamp Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| August 21, 2013 | CANDESARTAN | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 21, 2013 | LOSARTAN | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 21, 2013 | MOMETASONE FUROATE MONOHYDRATE AQUEOUS NASAL SPRAY | Schering-Plough Canada Inc. | New Drug Submission (NDS) · Admin |
| August 19, 2013 | TEVA-CAPECITABINE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| August 19, 2013 | TORRENT-LEVETIRACETAM | Torrent Pharmaceuticals Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 16, 2013 | ADVIL DAY/NIGHT CONVENIENCE PACK | Pfizer Consumer Healthcare, a division of Pfizer Canada ULC | New Drug Submission (NDS) · Labelling Only |
| August 16, 2013 | FERAHEME | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| August 16, 2013 | FERRLECIT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 16, 2013 | DOXORUBICIN PFS | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| August 16, 2013 | MONTELUKAST | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 16, 2013 | PEGASYS RBV | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 15, 2013 | PROLIA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 15, 2013 | ZAMINE 28; ZAMINE 21 | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 15, 2013 | EPIRUBICIN PFS | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| August 15, 2013 | RENAGEL | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Admin |
| August 15, 2013 | RENVELA | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Admin |
| August 15, 2013 | IDARUBICIN; IDARUBICIN PFS | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| August 15, 2013 | RATIO-IPRA SAL UDV | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| August 15, 2013 | RATIO-IPRATROPIUM UDV | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| August 15, 2013 | AJ-PACLITAXEL | Agila Jamp Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| August 15, 2013 | SDZ-SUMATRIPTAN | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 15, 2013 | SANDOZ SUMATRIPTAN | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 15, 2013 | COSMEGEN | Recordati Rare Diseases | New Drug Submission (NDS) · Admin |
| August 15, 2013 | LANSOPRAZOLE-15; LANSOPRAZOLE-30 | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| August 14, 2013 | APO-LORAZEPAM SUBLINGUAL | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 14, 2013 | VARILRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 14, 2013 | BERIPLEX P/N 500; BERIPLEX P/N 1000 | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 13, 2013 | ZAXINE | Salix Pharmaceuticals Inc | New Drug Submission (NDS) · Priority-NAS |
| August 13, 2013 | JETREA | Alcon Canada Inc. | New Drug Submission (NDS) · Priority-NAS |
| August 13, 2013 | AURO-LAMIVUDINE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 12, 2013 | CUBICIN | Cubist Pharmaceuticals Llc | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2013 | MOVISSE | Famy Care Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| August 12, 2013 | TETRABENAZINE TABLETS | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 12, 2013 | MYCOPHENOLATE MOFETIL TABLETS | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 9, 2013 | LOVENOX WITH PRESERVATIVE 300MG/3ML | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 9, 2013 | ENGERIX-B | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 8, 2013 | CONTINGENCY | Famy Care Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| August 8, 2013 | IDARUBICIN HYDROCHLORIDE INJECTION | Onco Therapies Limited | Abbreviated New Drug Submission (ANDS) · Other |
| August 8, 2013 | CICLOPIROX TOPICAL SOLUTION | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 8, 2013 | EPTIFIBATIDE INJECTION | Omega Laboratories Limited | Abbreviated New Drug Submission (ANDS) · Other |
| August 8, 2013 | OXYNEO | Purdue Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| August 8, 2013 | RATIO-VALPROIC | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| August 8, 2013 | RATIO-ACYCLOVIR | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| August 7, 2013 | MIRVALA 21; MIRVALA 28 | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 7, 2013 | VIREAD | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 7, 2013 | COMFORTIS | Elanco Division Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 6, 2013 | CAYSTON | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 6, 2013 | MYLAN-ZOLMITRIPTAN ODT | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 2, 2013 | KOMBOGLYZE | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| August 2, 2013 | CIPRO; CIPRO ORAL SUSPENSION | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 2, 2013 | CIPRO XL | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 1, 2013 | BYETTA (1.2 ML PREFILLED PEN, 5 MCG/DOSE); BYETTA (2.4 ML PREFILLED PEN, 10 MCG/DOSE) | Bristol-Myers Squibb Canada | New Drug Submission (NDS) · Admin |
| July 31, 2013 | NTP-DICLOFENAC SODIUM; NTP-DICLOFENAC SODIUM SR | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| July 31, 2013 | NTP-PRAVASTATIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 31, 2013 | NTP-ROSUVASTATIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 31, 2013 | ACC-METFORMIN | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| July 31, 2013 | NTP-DOXEPIN | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| July 31, 2013 | SANDOZ QUETIAPINE | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 30, 2013 | CEFTRIAXONE FOR INJECTION, USP | Pharmaceutical Partners Of Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 30, 2013 | MOZOBIL | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Admin |
| July 30, 2013 | NTP-DICLOFENAC POTASSIUM | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 30, 2013 | NTP-ETIDRONATE CALCIUM | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 30, 2013 | NTP-FAMOTIDINE | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| July 30, 2013 | MYLAN-EFAVIRENZ | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| July 30, 2013 | TEVA-EFAVIRENZ | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| July 30, 2013 | NTP-ENALAPRIL | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| July 29, 2013 | TUDORZA GENUAIR | Almirall S.A. | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 29, 2013 | NAPROXEN | Pharmel Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 29, 2013 | NTP-CITALOPRAM | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 29, 2013 | NTP-CLOBAZAM | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 29, 2013 | NTP-CLONIDINE | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| July 29, 2013 | NTP-DOXYCYCLINE TABLETS; NTP-DOXYCYCLINE CAPSULES | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| July 29, 2013 | AVONEX | Biogen Idec Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 26, 2013 | TARGIN | Purdue Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| July 26, 2013 | CLARITHROMYCIN | Sanis Health Inc. | New Drug Submission (NDS) · Admin |
| July 26, 2013 | GD-TRANEXAMIC ACID | Genmed A Division Of Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| July 26, 2013 | TEVA-METFORMIN | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| July 26, 2013 | NTP-BICALUTAMIDE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 26, 2013 | NTP-CARVEDILOL | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 26, 2013 | EXTRA STRENGTH ALLERGY RELIEF | Pharmel Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 26, 2013 | DESLORATADINE ALLERGY CONTROL | Pharmel Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 26, 2013 | NAT-CITALOPRAM | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| July 26, 2013 | AJ-GEMCITABINE | Agila Jamp Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| July 26, 2013 | AJ-FLUDARABINE | Agila Jamp Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| July 25, 2013 | INCIVEK | Vertex Pharmaceuticals (Canada) Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| July 25, 2013 | ANASTROZOLE TABLETS | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 25, 2013 | LATUDA | Sunovion Pharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 24, 2013 | NOVO-VERAMIL SR | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 24, 2013 | MINT-MONTELUKAST | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| July 24, 2013 | GEMCITABINE FOR INJECTION USP | Generic Medical Partners Inc | Abbreviated New Drug Submission (ANDS) · Other |
| July 24, 2013 | DOXORUBICIN HYDROCHLORIDE INJECTION | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| July 24, 2013 | PG-DOMPERIDONE | International Pharmaceutical Generics Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| July 24, 2013 | JAMP-PANTOPRAZOLE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| July 24, 2013 | NTP-AMOXICILLIN; NTP-AMOXICILLIN (SUGAR REDUCED) | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| July 23, 2013 | EPIRUBICIN HYDROCHLORIDE INJECTION | Omega Laboratories Limited | Abbreviated New Drug Submission (ANDS) · Other |
| July 23, 2013 | RIZATRIPTAN | Jubilant Life Sciences Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| July 23, 2013 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 23, 2013 | MYL-PREGABALIN | Mylan Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| July 22, 2013 | NASONEX | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 22, 2013 | NTP-ATENOLOL/CHLORTHALIDONE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 22, 2013 | MYLAN-ALMOTRIPTAN | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| July 22, 2013 | SANDOZ ALMOTRIPTAN | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 22, 2013 | APO-ALMOTRIPTAN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 22, 2013 | NTP-CANDESARTAN | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| July 22, 2013 | NTP-CILAZAPRIL | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 22, 2013 | AJ-CISATRACURIUM (WITH PRESERVATIVE); AJ-CISATRACURIUM (PRESERVATIVE FREE) | Agila Jamp Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| July 19, 2013 | VOTRIENT | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2013 | NTP-GLYBURIDE | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| July 19, 2013 | NTP-AMIODARONE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 19, 2013 | NTP-ATENOL | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| July 19, 2013 | NTP-ATORVASTATIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 19, 2013 | NTP-AZATHIOPRINE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 18, 2013 | MEKINIST | Glaxosmithkline Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 18, 2013 | RAN-IRBESARTAN | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 17, 2013 | GEMCITABINE FOR INJECTION | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 17, 2013 | CEFTRIAXONE SODIUM FOR INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 17, 2013 | CO CANDESARTAN | Cobalt Pharmaceuticals Incorporated | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 17, 2013 | MINT-GABAPENTIN | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| July 16, 2013 | TAFINLAR | Glaxosmithkline Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 16, 2013 | METACAM | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| July 16, 2013 | TOPOTECAN INJECTION | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| July 16, 2013 | CISPLATIN INJECTION | Pharmaceutical Partners Of Canada Inc | Abbreviated New Drug Submission (ANDS) · Other |
| July 16, 2013 | PMS-CISPLATIN | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 15, 2013 | PALANDRA 21; PALANDRA 28 | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| July 12, 2013 | MINT-CLOPIDOGREL | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| July 12, 2013 | ERIVEDGE | Hoffmann-La Roche Limited | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 12, 2013 | ADENOSINE INJECTION USP (PRE FILLED SYRINGE) | Agila Specialties Private Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 12, 2013 | RAN-LISINOPRIL | Ranbaxy Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 12, 2013 | KINERET | Swedish Orphan Biovitrum Ab (Publ) | Supplement to a New Drug Submission (SNDS) · Other |
| July 11, 2013 | KETALEAN | Bimeda-MTC Animal Health Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 10, 2013 | ILARIS | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 10, 2013 | METACAM 20 MG/ML SOLUTION FOR INJECTION | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| July 10, 2013 | CLINDAMYCIN IV INFUSION | Sandoz Canada Inc. | New Drug Submission (NDS) · Other |
| July 8, 2013 | KINEVAC | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| July 8, 2013 | COLGATE TOTAL - ADVANCED HEALTH (CLEAN BETWEEN VARIANT) | Colgate-Palmolive Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 8, 2013 | PRISTIQ | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2013 | ACCEL-METFORMIN | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| July 5, 2013 | KADIAN | Mayne Pharma International Pty Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2013 | RATIO-GLIMEPIRIDE | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| July 5, 2013 | PAL-TIZANIDINE | Paladin Labs Inc | Supplement to a New Drug Submission (SNDS) · Admin |
| July 5, 2013 | NTP-ACYCLOVIR | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 5, 2013 | NTP-ALPRAZOLAM | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| July 5, 2013 | NTP-TRAZODONE | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| July 5, 2013 | NTP-DOMPERIDONE | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| July 5, 2013 | MYLAN-RABEPRAZOLE | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| July 5, 2013 | INTUNIV XR | Shire Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 4, 2013 | NTP-TERAZOSIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 4, 2013 | MYLAN-BUPRENORPHINE/NALOXONE | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| July 4, 2013 | CLEVIPREX | The Medicines Company | Supplement to a New Drug Submission (SNDS) · Other |
| July 4, 2013 | RATIO-SALBUTAMOL | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| July 4, 2013 | JAMP-LOSARTAN HCTZ | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| July 4, 2013 | NTP-5-AMINOSALICYLIC ACID | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| July 4, 2013 | NTP-ALLOPURINOL | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| July 4, 2013 | NTP-OXYBUTYNIN | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| July 3, 2013 | BREO ELLIPTA | Glaxosmithkline Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 3, 2013 | RIVA-CIPROFLOXACIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 3, 2013 | ACCEL-OLANZAPINE ODT | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| July 3, 2013 | PROPADERM | Valeo Pharma Inc. | New Drug Submission (NDS) · Admin |
| July 2, 2013 | APO-QUINAPRIL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 2, 2013 | APO-QUINAPRIL | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 28, 2013 | ROPIVACAINE HYDROCHLORIDE INJECTION | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| June 28, 2013 | PREVNAR 13 | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2013 | APO-QUINAPRIL/HCTZ | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 28, 2013 | CISATRACURIUM OMEGA (WITHOUT PRESERVATIVE); CISATRACURIUM OMEGA (WITH PRESERVATIVE) | Omega Laboratories Limited | Abbreviated New Drug Submission (ANDS) · Other |
| June 28, 2013 | APO-VALGANCICLOVIR | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 28, 2013 | INSTANYL | Takeda Canada Incorporated | New Drug Submission (NDS) · Other |
| June 28, 2013 | DOXORUBICIN HYDROCHLORIDE FOR INJECTION, USP | Hospira Healthcare Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2013 | OCTAPLASMA | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| June 27, 2013 | PACLITAXEL INJECTION, USP | Onco Therapies Limited | Abbreviated New Drug Submission (ANDS) · Other |
| June 27, 2013 | VESANOID | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 27, 2013 | ESTROGEL PROPAK | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 26, 2013 | RATIO-INDOMETHACIN | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| June 26, 2013 | SILDENAFIL | Dominion Pharmacal | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 26, 2013 | DOM-SILDENAFIL | Dominion Pharmacal | Abbreviated New Drug Submission (ANDS) · Admin |
| June 26, 2013 | RIVA-RISPERIDONE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 26, 2013 | APO-IMIQUIMOD | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 26, 2013 | AJ-VANCOMYCIN | Agila Jamp Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 26, 2013 | TEVA-CLONAZEPAM | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| June 26, 2013 | DILTIAZEM TZ | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| June 26, 2013 | RATIO-METHOTREXATE SODIUM | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| June 24, 2013 | VELCADE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 24, 2013 | VELCADE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 24, 2013 | AGRIFLU | Novartis Vaccines And Diagnostics Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 24, 2013 | FLUAD (INFLUENZA VACCINE, INACTIVATED, ADJUVANTED MF59) | Novartis Vaccines And Diagnostics Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 24, 2013 | GAMMAGARD S/D | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| June 24, 2013 | FIBRISTAL | Watson Laboratories Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 24, 2013 | RIVA-QUETIAPINE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 21, 2013 | TASIGNA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 21, 2013 | KIVEXA | Viiv Healthcare Ulc | New Drug Submission (NDS) · Admin |
| June 21, 2013 | TRIZIVIR | Viiv Healthcare Ulc | New Drug Submission (NDS) · Admin |
| June 21, 2013 | JAMP-VANCOMYCIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| June 21, 2013 | BACITRACIN MD | Bio Agri Mix Lp | Abbreviated New Drug Submission (ANDS) · Other |
| June 20, 2013 | OFIRMEV | Cadence Pharmaceuticals Inc | New Drug Submission (NDS) · Other |
| June 20, 2013 | RATIO-PREGABALIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| June 20, 2013 | RATIO-PREGABALIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 19, 2013 | JAYDESS | Bayer Inc. | New Drug Submission (NDS) · Other |
| June 19, 2013 | BUSCOPAN | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| June 18, 2013 | AURO-VALSARTAN HCT | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 18, 2013 | ELIGARD | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 17, 2013 | RATIO-FLUVOXAMINE | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| June 17, 2013 | COMBIVIR | Viiv Healthcare Ulc | New Drug Submission (NDS) · Admin |
| June 14, 2013 | VICTRELIS TRIPLE | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 14, 2013 | FENTORA | Lundbeck Canada Inc | New Drug Submission (NDS) · Other |
| June 14, 2013 | CYMBALTA | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 14, 2013 | AMLODIPINE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 14, 2013 | CEFTRIAXONE SODIUM FOR INJECTION | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| June 14, 2013 | RATIO-TRAZODONE | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| June 14, 2013 | RATIO-ACLAVULANATE; RATIO-ACLAVULANATE 125F; RATIO-ACLAVULANATE 250F | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| June 14, 2013 | SANDOZ QUETIAPINE XRT | Sandoz Canada Inc. | New Drug Submission (NDS) · Admin |
| June 13, 2013 | COLD & SINUS RELIEF CAPSULES | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 13, 2013 | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN TABLETS | Lupin Limited | Abbreviated New Drug Submission (ANDS) · Other |
| June 13, 2013 | APO-TETRABENAZINE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 13, 2013 | GRANISETRON HYDROCHLORIDE INJECTION | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 13, 2013 | PMS-PROPOFOL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 13, 2013 | APO-IMATINIB | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 13, 2013 | NOVO-LEFLUNOMIDE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| June 13, 2013 | PANTOPRAZOLE FOR INJECTION | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| June 13, 2013 | BOVATEC 20 | Alpharma Canada Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| June 13, 2013 | AVATEC 20 | Alpharma Canada Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| June 13, 2013 | RIVA-PAROXETINE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 12, 2013 | AURO-ATORVASTATIN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 12, 2013 | APO-LANSOPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 12, 2013 | OMNITROPE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 12, 2013 | COMPONENT TE-200 IMPLANTS WITH TYLAN | Elanco Division Eli Lilly Canada Inc | New Drug Submission (NDS) · Other |
| June 11, 2013 | STRIVERDI RESPIMAT | Boehringer Ingelheim (Canada) Ltd. | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 7, 2013 | TELMISARTAN TABLETS | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 7, 2013 | TARO-CARBAMAZEPINE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 7, 2013 | YAZ PLUS | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 7, 2013 | TRISENOX | Lundbeck Canada Inc | New Drug Submission (NDS) · Priority |
| June 7, 2013 | VFEND | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 7, 2013 | MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION | Pharmel Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 7, 2013 | MINT-ROSUVASTATIN | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 7, 2013 | 3TC | Viiv Healthcare Ulc | New Drug Submission (NDS) · Admin |
| June 7, 2013 | HEPTOVIR | Glaxosmithkline Inc | New Drug Submission (NDS) · Admin |
| June 6, 2013 | REVLIMID | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 6, 2013 | DERACIN 22% GRANULAR PREMIX | Pharmgate Llc | Abbreviated New Drug Submission (ANDS) · Other |
| June 6, 2013 | MYLAN-PREGABALIN | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 6, 2013 | TEVA-LOVASTATIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| June 5, 2013 | VYLOMA | Valeant Canada Lp Valeant Canada S.E.C. | Supplement to a New Drug Submission (SNDS) · Other |
| June 5, 2013 | RATIO-SALBUTAMOL | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| June 5, 2013 | RATIO-AMCINONIDE | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| June 4, 2013 | JAMP-ZOPICLONE TABLETS | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| June 4, 2013 | RATIO-RIVASTIGMINE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| June 4, 2013 | MYLAN-NITRO PATCH 0.2; MYLAN-NITRO PATCH 0.4; MYLAN-NITRO PATCH 0.6; MYLAN-NITRO PATCH 0.8 | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| June 4, 2013 | MED-BICALUTAMIDE | Generic Medical Partners Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 4, 2013 | DESLORATADINE ALLERGY CONTROL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 4, 2013 | TNKASE | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 3, 2013 | MINT-RIVASTIGMINE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 3, 2013 | NOVO-VERAMIL; NOVO-VERAMIL SR | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| June 3, 2013 | NOVAMOXIN; NOVAMOXIN (SUGAR REDUCED) | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| May 31, 2013 | SANDOZ-CARBAMAZEPINE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| May 31, 2013 | NOVO-DESMOPRESSIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| May 31, 2013 | SOLIRIS | Alexion Pharma International Sarl | New Drug Submission (NDS) · Admin |
| May 31, 2013 | ZARAH 21; ZARAH 28 | Cobalt Pharmaceuticals Incorporated | Abbreviated New Drug Submission (ANDS) · Other |
| May 31, 2013 | PREVNAR 13 | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 31, 2013 | ACTEMRA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 30, 2013 | JAMP-OLANZAPINE ODT | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| May 30, 2013 | CYTARABINE | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| May 30, 2013 | LEVETIRACETAM | Jubilant Life Sciences Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| May 29, 2013 | XTANDI | Astellas Pharma Canada Inc | New Drug Submission (NDS) · Priority-NAS |
| May 29, 2013 | ABILIFY | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 29, 2013 | GEMCITABINE FOR INJECTION, USP | Onco Therapies Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 28, 2013 | ZYTIGA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 28, 2013 | TRICIRA LO (28 DAY); TRICIRA LO (21 DAY) | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 24, 2013 | RATIO-CLOBETASOL | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| May 24, 2013 | RATIO-FINASTERIDE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| May 24, 2013 | RATIO-SILDENAFIL R | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| May 24, 2013 | APO-LEVOCARB CR | Apotex Inc. | New Drug Submission (NDS) · Admin |
| May 24, 2013 | RATIO-MEMANTINE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| May 24, 2013 | AXUM | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| May 23, 2013 | VICTRELIS TRIPLE | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 23, 2013 | BRILINTA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 23, 2013 | PMS-TOPOTECAN | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 23, 2013 | CISATRACURIUM BESYLATE INJECTION (10 ML MULTIPLE DOSE VIALS WITH PRESERVATIVE); CISATRACURIUM BESYLATE INJECTION (PRESERVATIVE FREE) (5ML SINGLE DOSE VIALS) | Agila Specialties Private Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 23, 2013 | FONDAPARINUX SODIUM INJECTION | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| May 23, 2013 | YASMIN 21; YASMIN 28 | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 22, 2013 | CHAMPIX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 22, 2013 | ONSIOR | Novartis Animal Health Canada Inc. | New Drug Submission (NDS) · Admin |
| May 22, 2013 | ONSIOR | Novartis Animal Health Canada Inc. | New Drug Submission (NDS) · Admin |
| May 22, 2013 | ONSIOR | Novartis Animal Health Canada Inc. | New Drug Submission (NDS) · Admin |
| May 22, 2013 | ONSIOR | Novartis Animal Health Canada Inc. | New Drug Submission (NDS) · Admin |
| May 22, 2013 | M-ELOXYN | Pfizer Animal Health Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| May 22, 2013 | ONSIOR | Novartis Animal Health Canada Inc. | New Drug Submission (NDS) · Admin |
| May 22, 2013 | VINBLASTINE SULFATE INJECTION | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 22, 2013 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Agila Specialties Private Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 22, 2013 | RAN-TELMISARTAN HCTZ | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 22, 2013 | SANDOZ BUPROPION SR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 17, 2013 | DOM-VENLAFAXINE XR | Dominion Pharmacal | Abbreviated New Drug Submission (ANDS) · Admin |
| May 16, 2013 | VICTRELIS | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 16, 2013 | FLUDARABINE PHOSPHATE INJECTION | Onco Therapies Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 16, 2013 | HALOPERIDOL INJECTION USP | Pharmaceutical Partners Of Canada Inc | Abbreviated New Drug Submission (ANDS) · Other |
| May 15, 2013 | HUMATROPE | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 14, 2013 | VANCOMYCIN HYDROCHLORIDE CAPSULES USP | Strides Arcolab Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| May 14, 2013 | MINITRAN | Valeant Canada Lp Valeant Canada S.E.C. | Supplement to a New Drug Submission (SNDS) · Other |
| May 14, 2013 | CETRICLENZ | Ceva Animal Health Inc | New Drug Submission (NDS) · Admin |
| May 13, 2013 | ONGLYZA | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 13, 2013 | ALIMTA | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 13, 2013 | RHINARIS-CS ANTI-ALLERGIC NASAL MIST | Pendopharm Division Of De Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 13, 2013 | TILMOVET PREMIX | Huvepharma Eood | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 10, 2013 | DEPAKENE | Abbott Laboratories Co. | Supplement to a New Drug Submission (SNDS) · Other |
| May 10, 2013 | CO ATORVASTATIN | Cobalt Pharmaceuticals Incorporated | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 10, 2013 | RIVA-ATOMOXETINE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 10, 2013 | RATIO-FENOFIBRATE MC | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| May 10, 2013 | MUSCLE & BACK PAIN RELIEF WITH IBUPROFEN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| May 10, 2013 | SILDENAFIL | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 10, 2013 | ARZERRA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 9, 2013 | ALIMTA | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 9, 2013 | REVITALENS OCUTEC MULTI-PURPOSE SOLUTION | Amo Canada Company | New Drug Submission (NDS) · Other |
| May 9, 2013 | RATIO-CIPROFLOXACIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| May 9, 2013 | MINT-LOSARTAN | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| May 9, 2013 | DOMPERIDONE | Sanis Health Inc. | New Drug Submission (NDS) · Admin |
| May 9, 2013 | MAXALT; MAXALT RPD | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 9, 2013 | UVADEX | Therakos Inc | New Drug Submission (NDS) · Other |
| May 8, 2013 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLETS | Jubilant Life Sciences Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| May 8, 2013 | AURO-RISEDRONATE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 8, 2013 | IBUPROFEN LIQUID GEL CAPSULES; EXTRA STRENGTH IBUPROFEN LIQUID FILLED CAPSULES | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 8, 2013 | TEVA-LETROZOLE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| May 8, 2013 | ACCEL-LETROZOLE TABLETS USP | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| May 8, 2013 | AURO-LETROZOLE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 8, 2013 | CIPROFLOXACIN INTRAVENOUS INFUSION, BP | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 8, 2013 | RATIO-TAMSULOSIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| May 8, 2013 | RAN-FLUOXETINE | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 8, 2013 | APO-MEGESTROL | Apotex Inc. | New Drug Submission (NDS) · Admin |
| May 8, 2013 | ROSUVASTATIN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 8, 2013 | JAMP-SILDENAFIL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| May 8, 2013 | GD-VORICONAZOLE | Genmed A Division Of Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| May 7, 2013 | ONSIOR | Novartis Animal Health Canada Inc. | New Drug Submission (NDS) · Admin |
| May 7, 2013 | IVERMECTIN POUR-ON FOR CATTLE | Alberta Veterinary Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Admin |
| May 7, 2013 | ALENDRONATE-CHOLECALCIFEROL | Frosst A Division Of Merck Canada Inc | New Drug Submission (NDS) · Admin |
| May 7, 2013 | APIDRA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 7, 2013 | LANTUS | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 6, 2013 | HEXABRIX 200; HEXABRIX 320 | Guerbet | New Drug Submission (NDS) · Admin |
| May 6, 2013 | THYMOGLOBULIN | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Admin |
| May 6, 2013 | OCTAPLEX | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| May 6, 2013 | NALOXONE HYDROCHLORIDE INJECTION USP | Alveda Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 6, 2013 | NOVAMOXIN; NOVAMOXIN (SUGAR REDUCED) | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2013 | ATLANTISCAN (18F-FLUORO-2-DEOXYGLUCOSE) | Capital District Health Authority | Abbreviated New Drug Submission (ANDS) · Other |
| May 3, 2013 | CERVARIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 1, 2013 | HYDRALAZINE HYDROCHLORIDE INJECTION USP | Pharmaceutical Partners Of Canada Inc | Abbreviated New Drug Submission (ANDS) · Other |
| May 1, 2013 | METFORMIN TABLETS | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| May 1, 2013 | AURO-IRBESARTAN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 1, 2013 | MOMETASONE | Frosst A Division Of Merck Canada Inc | New Drug Submission (NDS) · Admin |
| May 1, 2013 | PREGABALIN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 30, 2013 | DICETEL | Abbott Laboratories Co. | Supplement to a New Drug Submission (SNDS) · Other |
| April 30, 2013 | FLUDARA | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Admin |
| April 30, 2013 | CLOLAR | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Admin |
| April 30, 2013 | APO-TRIMIPRAMINE | Apotex Inc. | New Drug Submission (NDS) · Admin |
| April 29, 2013 | EPTIFIBATIDE INJECTION | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| April 29, 2013 | AURO-FINASTERIDE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 29, 2013 | EPTIFIBATIDE INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 29, 2013 | TEVA-IRBESARTAN/HCTZ | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 25, 2013 | NU-ACYCLOVIR | Nu-Pharm Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 25, 2013 | PMS-NEVIRAPINE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 25, 2013 | DUOTRAV PQ | Alcon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| April 24, 2013 | ALEVE | Bayer Inc Consumer Care | Supplement to a New Drug Submission (SNDS) · Other |
| April 24, 2013 | INTRALIPID 10%; INTRALIPID 20%; INTRALIPID 30% | Fresenius Kabi Ag | Supplement to a New Drug Submission (SNDS) · Other |
| April 24, 2013 | PROZINC | Boehringer Ingelheim (Canada) Ltd. | New Drug Submission (NDS) · Other |
| April 23, 2013 | ELOXATIN | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 23, 2013 | AJ-CYTARABINE | Agila Jamp Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| April 22, 2013 | AURO-SIMVASTATIN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 22, 2013 | AMPHOTERICIN B FOR INJECTION USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 22, 2013 | MYLAN-EXEMESTANE | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| April 22, 2013 | FUROSEMIDE INJECTION USP | Alveda Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 19, 2013 | TIMENTIN | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 19, 2013 | REMODULIN | United Therapeutics Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 19, 2013 | MYOZYME | Genzyme Canada A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 18, 2013 | XARELTO | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 18, 2013 | APO-MODAFINIL | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 18, 2013 | APO-GLICLAZIDE MR | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 18, 2013 | RATIO-BRIMONIDINE | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| April 18, 2013 | RATIO-LEVOBUNOLOL | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| April 18, 2013 | RIZATRIPTAN ODT | Abri Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| April 18, 2013 | ZOPICLONE | Abri Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| April 18, 2013 | DICLOFENAC MISOPROSTOL | Abri Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| April 17, 2013 | ALLERNIX MULTI SYMPTOM | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| April 17, 2013 | RATIO-BACLOFEN | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| April 17, 2013 | RATIO-SOTALOL | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| April 17, 2013 | IVERMECTIN LIQUID FOR HORSES | Alberta Veterinary Laboratories Ltd | New Drug Submission (NDS) · Other |
| April 16, 2013 | ZANOSAR STERILE POWDER | Paladin Labs Inc | New Drug Submission (NDS) · Admin |
| April 16, 2013 | CLARITIN LIQUID CAPSULES | Schering-Plough Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| April 16, 2013 | ENABLEX | Merus Labs Luxco S. A R.L. | New Drug Submission (NDS) · Admin |
| April 16, 2013 | RIVA-PREGABALIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 15, 2013 | RATIO-FLUTICASONE | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| April 15, 2013 | RIVA-ALPRAZOLAM | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 15, 2013 | AURO-ANASTROZOLE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 12, 2013 | PERJETA; PERJETA (PERJETA-HERCEPTIN COMBO PACK) | Hoffmann-La Roche Limited | New Drug Submission (NDS) · Priority-NAS |
| April 12, 2013 | TEVA-ELETRIPTAN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| April 12, 2013 | AURO-VALACYCLOVIR | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 12, 2013 | CEFAZOLIN FOR INJECTION | Novopharm Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 12, 2013 | FUROSEMIDE INJECTION | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 12, 2013 | PMS-ROSUVASTATIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 12, 2013 | CEFAZOLIN FOR INJECTION | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| April 12, 2013 | TORRENT-OLANZAPINE ODT | Torrent Pharmaceuticals Limited | Abbreviated New Drug Submission (ANDS) · Other |
| April 12, 2013 | PMS-ATOMOXETINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 12, 2013 | LOSARTAN/HCTZ | Frosst A Division Of Merck Canada Inc | New Drug Submission (NDS) · Admin |
| April 11, 2013 | VYVANSE | Shire Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 10, 2013 | GANCICLOVIR FOR INJECTION USP | Pharmaceutical Partners Of Canada Inc | Abbreviated New Drug Submission (ANDS) · Other |
| April 10, 2013 | PMS-LATANOPROST-TIMOLOL | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 10, 2013 | SERC | Abbott Laboratories Co. | Supplement to a New Drug Submission (SNDS) · Other |
| April 8, 2013 | RAN-LOSARTAN | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 5, 2013 | FIRMAGON | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 4, 2013 | FYCOMPA | Eisai Limited | New Drug Submission (NDS) · New Active Substance (NAS) |
| April 3, 2013 | TECFIDERA | Biogen Idec Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| April 3, 2013 | THROMBATE III | Grifols Therapeutics Llc | Supplement to a New Drug Submission (SNDS) · Other |
| April 2, 2013 | APO-IMATINIB | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 2, 2013 | TEVA-IMATINIB | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| April 2, 2013 | BL LATANOPROST | Bausch & Lomb Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 2, 2013 | TEVA-IMATINIB | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 2, 2013 | APO-IMATINIB | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 28, 2013 | APO-AMLODIPINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 28, 2013 | CO DORZOTIMOLOL | Cobalt Pharmaceuticals Incorporated | Abbreviated New Drug Submission (ANDS) · Other |
| March 28, 2013 | OMNARIS HFA | Takeda Canada Incorporated | New Drug Submission (NDS) · Other |
| March 28, 2013 | EUGLUCON | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 28, 2013 | RIVA-MONTELUKAST FC | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 28, 2013 | VAQTA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 27, 2013 | MYLAN-RISPERIDONE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 27, 2013 | NOVO-LEXIN | Novopharm Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 26, 2013 | LEUCOVORIN CALCIUM INJECTION | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 26, 2013 | PMS-AMLODIPINE-ATORVASTATIN | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 26, 2013 | APO-WARFARIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 26, 2013 | XERESE | Valeant Canada Lp Valeant Canada S.E.C. | New Drug Submission (NDS) · Other |
| March 26, 2013 | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Jubilant Life Sciences Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| March 26, 2013 | FUROSEMIDE SPECIAL INJECTION | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 26, 2013 | GABAPENTIN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 26, 2013 | MAR-DOMPERIDONE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 26, 2013 | PREGABALIN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| March 26, 2013 | DRAXIMAGE SODIUM IODIDE I 131 CAPSULE | Jubilant Draximage Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 25, 2013 | MAR-SILDENAFIL | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 25, 2013 | TEVA-ALENDRONATE-CHOLECALCIFEROL | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| March 22, 2013 | SANDOZ QUETIAPINE XR | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 22, 2013 | IPG-SILDENAFIL | International Pharmaceutical Generics Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| March 21, 2013 | ZONALON CREAM 5% | Valeant Canada Lp Valeant Canada S.E.C. | New Drug Submission (NDS) · Admin |
| March 21, 2013 | CYTOSAR | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 21, 2013 | ALERTEC | Teva Pharma B.V. | New Drug Submission (NDS) · Admin |
| March 21, 2013 | NEUPRO | Ucb Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| March 20, 2013 | AFINITOR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 20, 2013 | RATIO-CEFUROXIME | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| March 19, 2013 | RAN-OMEPRAZOLE | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 19, 2013 | RAN-OLANZAPINE | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 19, 2013 | ZOPICLONE | Apotex Inc. | New Drug Submission (NDS) · Admin |
| March 19, 2013 | RETISERT | Bausch & Lomb Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 19, 2013 | APO-AMITRIPTYLINE | Apotex Inc. | New Drug Submission (NDS) · Admin |
| March 18, 2013 | AURO-FLUOXETINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 18, 2013 | DOM-PREGABALIN | Dominion Pharmacal | Abbreviated New Drug Submission (ANDS) · Admin |
| March 18, 2013 | APO-ALLOPURINOL | Apotex Inc. | New Drug Submission (NDS) · Admin |
| March 18, 2013 | JAMP-LEVETIRACETAM | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| March 18, 2013 | ULTRA-TECKNEKOW DTE | Mallinckrodt Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 15, 2013 | REGULAR STRENGTH ANALGESIC AND MUSCLE RELAXANT CAPLETS | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| March 15, 2013 | IPG-DOMPERIDONE | International Pharmaceutical Generics Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| March 15, 2013 | ROPIVACAINE HYDROCHLORIDE INJECTION, USP | Hospira Healthcare Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 15, 2013 | CISPLATIN INJECTION | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| March 15, 2013 | AURO-LOSARTAN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 15, 2013 | APO-MOMETASONE (AQUEOUS NASAL SPRAY) | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 14, 2013 | APO-ROSIGLITAZONE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 14, 2013 | DICLECTIN | Duchesnay Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2013 | GLUCOVISION | Centre For Probe Development And Commercialization | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2013 | CERETEC | Ge Healthcare Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2013 | TYLAN SOLUBLE | Elanco Division Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2013 | VETALAR | Bioniche Animal Health Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2013 | RATIO-BUPROPION SR | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| March 12, 2013 | RATIO-MOMETASONE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| March 12, 2013 | PMS-GEMFIBROZIL | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| March 12, 2013 | RAN-MONTELUKAST | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 12, 2013 | RAN-LANSOPRAZOLE | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 11, 2013 | ESTROGEL PROPAK | Merck Canada Inc | New Drug Submission (NDS) · Labelling Only |
| March 11, 2013 | BRILINTA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 11, 2013 | STIVARGA | Bayer Inc. | New Drug Submission (NDS) · Priority-NAS |
| March 8, 2013 | TEVA-QUETIAPINE XR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 8, 2013 | TEVA-QUETIAPINE XR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 8, 2013 | ZYCLARA | Valeant Canada Lp Valeant Canada S.E.C. | New Drug Submission (NDS) · Admin |
| March 8, 2013 | VYLOMA | Valeant Canada Lp Valeant Canada S.E.C. | New Drug Submission (NDS) · Admin |
| March 8, 2013 | AIROMIR | Valeant Canada Lp Valeant Canada S.E.C. | New Drug Submission (NDS) · Admin |
| March 8, 2013 | NIDAGEL | Valeant Canada Lp Valeant Canada S.E.C. | New Drug Submission (NDS) · Admin |
| March 8, 2013 | QVAR | Valeant Canada Lp Valeant Canada S.E.C. | New Drug Submission (NDS) · Admin |
| March 8, 2013 | MINITRAN | Valeant Canada Lp Valeant Canada S.E.C. | New Drug Submission (NDS) · Admin |
| March 8, 2013 | ALDARA | Valeant Canada Lp Valeant Canada S.E.C. | New Drug Submission (NDS) · Admin |
| March 8, 2013 | INTANZA | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 7, 2013 | LEVOTHYROXINE SODIUM FOR INJECTION | Pharmaceutical Partners Of Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 7, 2013 | JENTADUETO | Boehringer Ingelheim (Canada) Ltd. | New Drug Submission (NDS) · Other |
| March 7, 2013 | INVEGA SUSTENNA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 7, 2013 | PEGASYS RBV | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 7, 2013 | PEGASYS (PEGINTERFERON ALFA-2A) | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 7, 2013 | PRO-FLUCONAZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 7, 2013 | TAMBOCOR | Valeant Canada Lp Valeant Canada S.E.C. | New Drug Submission (NDS) · Admin |
| March 7, 2013 | PRO-FLUCONAZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 7, 2013 | TRAMADOL/ACETAMINOPHEN TABLETS | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| March 6, 2013 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 6, 2013 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Alveda Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| March 6, 2013 | BETASERON (INTERFERON BETA-1B) | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 6, 2013 | MYRBETRIQ | Astellas Pharma Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| March 5, 2013 | COMPLERA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2013 | CO PREGABALIN | Cobalt Pharmaceuticals Incorporated | Abbreviated New Drug Submission (ANDS) · Other |
| March 5, 2013 | DORIBAX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2013 | FLUZONE | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 5, 2013 | NIMENRIX | Glaxosmithkline Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| March 4, 2013 | VIMPAT | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 1, 2013 | SOLIRIS | Alexion Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 1, 2013 | GEMCITABINE FOR INJECTION | Alveda Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| March 1, 2013 | PROCTOFOAM HC | Duchesnay Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 28, 2013 | RALGRO | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| February 28, 2013 | VETMULIN PREMIX | Huvepharma Eood | Abbreviated New Drug Submission (ANDS) · Other |
| February 27, 2013 | GEMCITABINE INJECTION | Hospira Healthcare Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 27, 2013 | MEDPRO DEFENSE NOCOLYSE | A.M.G. Medical Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 27, 2013 | VFEND | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 26, 2013 | PILOCARPINE HYDROCHLORIDE TABLETS USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 26, 2013 | RATIO-ZOPICLONE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| February 26, 2013 | MINT-SERTRALINE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 26, 2013 | RATIO-CARVEDILOL | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| February 26, 2013 | RIVA-OMEPRAZOLE DR | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 25, 2013 | ACID CONTROL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 25, 2013 | TIAMULIN 1.78% PREMIX | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 22, 2013 | MYLAN-ATOVAQUONE/PROGUANIL | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| February 22, 2013 | CYTARABINE INJECTION | Onco Therapies Limited | Abbreviated New Drug Submission (ANDS) · Other |
| February 22, 2013 | RATIO-TOPISALIC | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| February 22, 2013 | AJ-ADENOSINE | Agila Jamp Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 22, 2013 | JAMP-GABAPENTIN TABLETS | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| February 22, 2013 | JAMP-FLUOXETINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 22, 2013 | MED-RIVASTIGMINE | Generic Medical Partners Inc | Abbreviated New Drug Submission (ANDS) · Other |
| February 22, 2013 | PMS-TETRABENAZINE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 22, 2013 | FABRAZYME | Genzyme Canada A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 21, 2013 | GLEEVEC | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 21, 2013 | ORENCIA | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| February 20, 2013 | LUMIGAN PF | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 20, 2013 | NEORAL; SANDIMMUNE IV | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 19, 2013 | MASTIMIN 50 | Diversey Inc | New Drug Submission (NDS) · Admin |
| February 18, 2013 | PMS-PREGABALIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 18, 2013 | SILDENAFIL CITRATE | Jubilant Life Sciences Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| February 18, 2013 | COMPONENT TE-S IMPLANTS WITH TYLAN | Elanco Division Eli Lilly Canada Inc | New Drug Submission (NDS) · Admin |
| February 18, 2013 | COMPONENT TE-S IMPLANTS | Elanco Division Eli Lilly Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 18, 2013 | COMPONENT E-C IMPLANTS | Elanco Division Eli Lilly Canada Inc | New Drug Submission (NDS) · Admin |
| February 18, 2013 | COMPONENT E-C IMPLANTS WITH TYLAN | Elanco Division Eli Lilly Canada Inc | New Drug Submission (NDS) · Admin |
| February 18, 2013 | COMPONENT TE-H IMPLANTS | Elanco Division Eli Lilly Canada Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 18, 2013 | COMPONENT E-S IMPLANTS | Elanco Division Eli Lilly Canada Inc | New Drug Submission (NDS) · Admin |
| February 18, 2013 | COMPONENT E-H IMPLANTS | Elanco Division Eli Lilly Canada Inc | New Drug Submission (NDS) · Admin |
| February 18, 2013 | COMPONENT TE-H IMPLANTS WITH TYLAN | Elanco Division Eli Lilly Canada Inc | New Drug Submission (NDS) · Admin |
| February 18, 2013 | COMPONENT E-S IMPLANTS WITH TYLAN | Elanco Division Eli Lilly Canada Inc | New Drug Submission (NDS) · Admin |
| February 18, 2013 | COMPONENT E-H IMPLANTS WITH TYLAN | Elanco Division Eli Lilly Canada Inc | New Drug Submission (NDS) · Admin |
| February 15, 2013 | PMS-TELMISARTAN-HCTZ | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 15, 2013 | LUCENTIS | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 15, 2013 | RIVA-LETROZOLE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 15, 2013 | APO-FENTANYL MATRIX | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 15, 2013 | ZOLEDRONIC ACID-Z | Sandoz Canada Inc. | New Drug Submission (NDS) · Admin |
| February 15, 2013 | COSOPT (PRESERVATIVE FREE) | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 15, 2013 | DOVOBET GEL | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 15, 2013 | EDURANT | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 15, 2013 | APO-PREGABALIN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 15, 2013 | RAN-PREGABALIN | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 15, 2013 | TEVA-PREGABALIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 15, 2013 | TEVA-PREGABALIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 15, 2013 | TEVA-PREGABALIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| February 15, 2013 | MYLAN-PREGABALIN | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| February 15, 2013 | SANDOZ PREGABALIN | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 14, 2013 | RIVA-ZOLMITRIPTAN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 14, 2013 | JAMP-IBUPROFEN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| February 14, 2013 | ZOPICLONE TABLETS | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 14, 2013 | AMLODIPINE TABLETS | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 14, 2013 | ONDANSETRON TABLETS | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 14, 2013 | CIPROFLOXACIN TABLETS | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 14, 2013 | VISUDYNE | Valeant Canada Lp Valeant Canada S.E.C. | New Drug Submission (NDS) · Admin |
| February 14, 2013 | ACCEL-FLUOXETINE CAPSULES BP | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 14, 2013 | RIVA-PREGABALIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 14, 2013 | PREGABALIN | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| February 14, 2013 | CITALOPRAM TABLETS | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 14, 2013 | TOCTINO | Glaxosmithkline Inc | New Drug Submission (NDS) · Admin |
| February 14, 2013 | PREGABALIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 14, 2013 | SIMVASTATIN TABLETS | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 14, 2013 | SANDOZ LETROZOLE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| February 14, 2013 | LETROZOLE | Pro Doc Limitee | New Drug Submission (NDS) · Admin |
| February 14, 2013 | DUOTRAV Q | Alcon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 14, 2013 | MOTRIN; MOTRIN LIQUID GELS 200 MG; MOTRIN GELCAPS; MOTRIN CAPLET | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 14, 2013 | ADVIL COLD, COUGH & FLU NIGHTTIME | Pfizer Consumer Healthcare, a division of Pfizer Canada ULC | New Drug Submission (NDS) · Labelling Only |
| February 13, 2013 | AREPANRIX H5N1 (AS03 ADJUVANTED QUEBEC H5N1 INFLUENZA VACCINE) | Id Biomedical Corporation Of Quebec | New Drug Submission (NDS) · New Active Substance (NAS) |
| February 13, 2013 | ACLASTA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2013 | GLYCOPYRROLATE INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2013 | PMS-PREGABALIN | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 13, 2013 | AMOXICILLIN CAPSULES; AMOXICILLIN CHEWABLE TABLETS; AMOXICILLIN GRANULES FOR ORAL SUSPENSION; AMOXICILLIN SUGAR-REDUCED GRANULES FOR ORAL SUSPENSION | Sivem Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| February 13, 2013 | ACCEL-BICALUTAMIDE TABLETS USP | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 13, 2013 | ACCEL-MYCOPHENOLATE MOFETIL TABLETS | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 13, 2013 | ACCEL-MONTELUKAST SODIUM TABLETS | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 13, 2013 | ACCEL-MYCOPHENOLATE MOFETIL CAPSULES | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 13, 2013 | ACCEL-QUETIAPINE TABLETS | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 13, 2013 | ACCEL-CANDESARTAN CILEXETIL TABLETS | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 13, 2013 | ACCEL-FINASTERIDE TABLETS USP | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 13, 2013 | ACCEL-ALENDRONATE SODIUM TABLETS | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 13, 2013 | LYSTEDA | Ferring Inc. | New Drug Submission (NDS) · Other |
| February 11, 2013 | PROMETRIUM | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 11, 2013 | CLOPIDOGREL | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 11, 2013 | DIVALPROEX | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 11, 2013 | TARO-SUMATRIPTAN | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 11, 2013 | SILDENAFIL | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 11, 2013 | SANDOZ FLUVASTATIN | Sandoz Canada Inc. | New Drug Submission (NDS) · Admin |
| February 11, 2013 | DILTIAZEM CD | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 11, 2013 | ENALAPRIL | Sanis Health Inc. | New Drug Submission (NDS) · Admin |
| February 11, 2013 | CLINDAMYCIN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 11, 2013 | INFLUVAC | Abbott Laboratories Co. | Supplement to a New Drug Submission (SNDS) · Other |
| February 11, 2013 | NAF PLUS | Pharmalogic Pet Services Of Montreal | New Drug Submission (NDS) · Other |
| February 10, 2013 | NARKETAN | Vetoquinol N A Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 8, 2013 | EXJADE | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 8, 2013 | SANDOZ FENOFIBRATE E | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 8, 2013 | VINCRISTINE SULFATE INJECTION | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 8, 2013 | AURO-MELOXICAM | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 8, 2013 | VINBLASTINE SULPHATE INJECTION | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| February 8, 2013 | LUTERA 21; LUTERA 28 | Cobalt Pharmaceuticals Incorporated | Abbreviated New Drug Submission (ANDS) · Other |
| February 8, 2013 | PMS-TRAMADOL-ACET | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 7, 2013 | GENOTROPIN (MINIQUICK); GENOTROPIN (GOQUICK) | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 7, 2013 | ZOSTAVAX; ZOSTAVAX II | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 5, 2013 | AURO-MONTELUKAST | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 5, 2013 | AGGRASTAT | Correvio (Uk) Ltd | New Drug Submission (NDS) · Admin |
| February 4, 2013 | NOVO-ROSUVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Labelling Only |
| February 4, 2013 | NOVO-ROSUVASTATIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| February 3, 2013 | APO-ADEFOVIR | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 1, 2013 | ADCETRIS | Seattle Genetics Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 31, 2013 | TRANEXAMIC ACID TABLETS | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 31, 2013 | MYLAN-AMLODIPINE/ATORVASTATIN | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| January 31, 2013 | KETASET | Pfizer Canada Inc., Animal Health Group | Supplement to a New Drug Submission (SNDS) · Other |
| January 30, 2013 | APO-CANDESARTAN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 30, 2013 | DOXORUBICIN HYDROCHLORIDE INJECTION | Omega Laboratories Limited | Abbreviated New Drug Submission (ANDS) · Other |
| January 30, 2013 | ADENOSINE INJECTION USP | Agila Specialties Private Limited | Abbreviated New Drug Submission (ANDS) · Other |
| January 30, 2013 | PICATO | Leo Pharma Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 30, 2013 | SANDOZ DICLOFENAC MISOPROSTOL | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 30, 2013 | KETOTIFEN OPHTHALMIC SOLUTION | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 29, 2013 | CALCITRIOL INJECTION USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 29, 2013 | CEFAZOLIN FOR INJECTION, USP | Pharmaceutical Partners Of Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 29, 2013 | CEFAZOLIN FOR INJECTION, USP | Pharmaceutical Partners Of Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 29, 2013 | GAMUNEX | Grifols Therapeutics Llc | Supplement to a New Drug Submission (SNDS) · Priority |
| January 28, 2013 | VICTRELIS | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 28, 2013 | BIOTRUE MULTI-PURPOSE SOLUTION | Bausch & Lomb Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 28, 2013 | DENAGARD 12.5% | Novartis Animal Health Canada Inc. | New Drug Submission (NDS) · Admin |
| January 28, 2013 | TEVA-KETOPROFEN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| January 27, 2013 | CIPROFLOXACIN INTRAVENOUS INFUSION | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| January 25, 2013 | ACID REDUCER | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| January 25, 2013 | AFINITOR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2013 | JAMP-ALPRAZOLAM | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| January 23, 2013 | TEVA-RAMIPRIL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 23, 2013 | TEVA-RAMIPRIL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 23, 2013 | PAT-DARUNAVIR | Patriot A Division Of Janssen Inc | New Drug Submission (NDS) · Admin |
| January 22, 2013 | ROTARIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 21, 2013 | PENTASA | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2013 | MAR-MONTELUKAST | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 18, 2013 | MAR-MONTELUKAST | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 17, 2013 | MYLAN-RIZATRIPTAN | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 17, 2013 | LEVETIRACETAM | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| January 17, 2013 | REYATAZ | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| January 17, 2013 | WINDEX MULTI-SURFACE DISINFECTANT | S C Johnson And Son Ltd | New Drug Submission (NDS) · Other |
| January 17, 2013 | FENTANYL TRANSDERMAL SYSTEM 25; FENTANYL TRANSDERMAL SYSTEM 50; FENTANYL TRANSDERMAL SYSTEM 75; FENTANYL TRANSDERMAL SYSTEM 100 | Aveva Drug Delivery Systems Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 16, 2013 | TEVA-CLONIDINE | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| January 16, 2013 | MAR-QUETIAPINE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 16, 2013 | NAROPIN | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 16, 2013 | CUROSURF | Chiesi Farmaceutici S P A | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2013 | RIFATER | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 15, 2013 | ZITHROMAX; ZITHROMAX FOR INTRAVENOUS INJECTION | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 14, 2013 | ADVIL COLD & SINUS CONVENIENCE PACK | Pfizer Consumer Healthcare, a division of Pfizer Canada ULC | New Drug Submission (NDS) · Labelling Only |
| January 14, 2013 | ISOPTIN SR | Abbott Laboratories Co. | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2013 | MAR-ZOLMITRIPTAN | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 11, 2013 | TOPOTECAN INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 10, 2013 | ANALGESIC AND MUSCLE RELAXANT CAPLETS | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| January 10, 2013 | TRIDURAL | Paladin Labs Inc | New Drug Submission (NDS) · Admin |
| January 10, 2013 | MAR-SERTRALINE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 10, 2013 | RATIO-METFORMIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| January 10, 2013 | OMNARIS | Takeda Canada Incorporated | New Drug Submission (NDS) · Admin |
| January 10, 2013 | DOM-ATORVASTATIN | Dominion Pharmacal | Abbreviated New Drug Submission (ANDS) · Admin |
| January 10, 2013 | AFINITOR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 9, 2013 | NOVO-DESMOPRESSIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2013 | RAN-TELMISARTAN | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 9, 2013 | IPG-ZOLMITRIPTAN | International Pharmaceutical Generics Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| January 8, 2013 | RAN-AMLODIPINE | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 8, 2013 | LOSARTAN | Frosst A Division Of Merck Canada Inc | New Drug Submission (NDS) · Admin |
| January 8, 2013 | GD-LISINOPRIL | Genmed A Division Of Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| January 8, 2013 | JAMP-LOSARTAN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| January 8, 2013 | MED-ROSUVASTATIN | Generic Medical Partners Inc | Abbreviated New Drug Submission (ANDS) · Other |
| January 8, 2013 | PANTOLOC | Takeda Canada Incorporated | New Drug Submission (NDS) · Admin |
| January 8, 2013 | APO-FLUNISOLIDE NASAL SPRAY | Apotex Inc. | New Drug Submission (NDS) · Admin |
| January 8, 2013 | ENALAPRIL/HCTZ | Frosst A Division Of Merck Canada Inc | New Drug Submission (NDS) · Admin |
| January 7, 2013 | SEBIVO | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 7, 2013 | IBUPROFEN + METHOCARBAMOL CAPLETS | International Pharmaceutical Generics Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| January 7, 2013 | ACCEL-AMLODIPINE | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| January 7, 2013 | ACCEL-AMLODIPINE | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| January 7, 2013 | PMS-ATORVASTATIN | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 7, 2013 | VIRACEPT | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2013 | PMS-BOSENTAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2013 | APO-CLOPIDOGREL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 4, 2013 | SODIUM IODIDE I 131 CAPSULES | Mallinckrodt Canada Ulc | New Drug Submission (NDS) · Admin |
| January 4, 2013 | KIT FOR THE PREPARATION OF TECHNETIUM (TC 99M) SESTAMIBI INJECTION | Mallinckrodt Canada Ulc | New Drug Submission (NDS) · Admin |
| January 4, 2013 | THALLOUS CHLORIDE TI 201 INJECTION | Mallinckrodt Canada Ulc | New Drug Submission (NDS) · Admin |
| January 4, 2013 | ULTRATAG RBC | Mallinckrodt Canada Ulc | New Drug Submission (NDS) · Admin |
| January 4, 2013 | ULTRA-TECHNEKOW DTE | Mallinckrodt Canada Ulc | New Drug Submission (NDS) · Admin |
| January 4, 2013 | SODIUM IODIDE 1 131 ORAL SOLUTION | Mallinckrodt Canada Ulc | New Drug Submission (NDS) · Admin |
| January 4, 2013 | GALLIUM (GA 67) CITRATE INJECTION | Mallinckrodt Canada Ulc | New Drug Submission (NDS) · Admin |
| January 4, 2013 | HIGH PURITY INDIUM CHLORIDE IN 111 STERILE SOLUTION | Mallinckrodt Canada Ulc | New Drug Submission (NDS) · Admin |
| January 4, 2013 | TECHNESCAN PYP | Mallinckrodt Canada Ulc | New Drug Submission (NDS) · Admin |
| January 4, 2013 | SODIUM IODIDE I 123 CAPSULES | Mallinckrodt Canada Ulc | New Drug Submission (NDS) · Admin |
| January 3, 2013 | CAELYX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 3, 2013 | ANALGESIC AND MUSCLE RELAXANT | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 3, 2013 | PENTASA | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 3, 2013 | TECHNESCAN MAG3 | Mallinckrodt Canada Ulc | New Drug Submission (NDS) · Admin |
| January 3, 2013 | OCTREOSCAN | Mallinckrodt Canada Ulc | New Drug Submission (NDS) · Admin |
| January 2, 2013 | DAXAS | Takeda Canada Incorporated | New Drug Submission (NDS) · Admin |
| January 2, 2013 | ENALAPRIL | Frosst A Division Of Merck Canada Inc | New Drug Submission (NDS) · Admin |
| January 2, 2013 | TEVA-TRYPTOPHAN | Teva Canada Limited | New Drug Submission (NDS) · Admin |
| January 2, 2013 | RIVA-SILDENAFIL | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 2, 2013 | RIVA-MONTELUKAST; RIVA-MONTELUKAST FC | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |